Results Out30 Sep 2024 18:12
Restructuring of share capital and debt. Private placing to raise £10m.Nasdaq listing binned. Annual sales of around 2,200 tests. Loss before tax $45m. New chairman installed with Mills becoming nonex director. Pretty depressing outlook.